Regulatory strategy is a fifth practice alongside the four already named, offering regulatory insight and writing support tied to product development, launch, and life cycle planning. Engagements run across pharmaceutical, medical device, and diagnostics organizations, reaching from startup CXOs to business unit heads at Fortune 100 companies. Economic evidence is delivered as analytical models and custom tools built for particular stakeholders, among them payers, physicians, pharmacists, and hospital purchasers, while communications output takes the form of journal publications, conference posters, and white papers. A digital group supports both with real-world data analytics, health economic modeling, interactive tools and data visualization, app and website development, and CRO and clinical trial support services. Recent peer-reviewed papers cover artificial intelligence in smart infusion pump technology, hereditary antithrombin deficiency in pediatric patients, and real-world cardiac events among chronic lymphocytic leukemia patients on covalent Bruton's tyrosine kinase inhibitors.
Boston Strategic Partners
Boston Strategic Partners (BSP) is a specialized healthcare consulting firm providing strategic advisory, health economics and outcomes research (HEOR), medical communications, and financial advisory services. Catering to life sciences companies, academic institutions, and NGOs, BSP combines deep clinical insight with analytical rigor to drive commercial success and advance healthcare delivery.
